Latest Updates

Sales in the third quarter rose 13 per cent to 15.6 billion Swiss francs ($15.64 billion), the Basel-based drugmaker said, citing…

The trial evaluated Lilly's pegilodecakin plus Folfox, which is a combination of chemotherapy drugs, compared to Folfox alone in…

Alexion's offer of $6.30 per share represents a premium of 72.6 per cent to Achillion stock's close

The United States Food and Drug Administration (US FDA) also warned the firm that until it corrects all violations, it may…

It will witness stakeholders in the pharma industry brainstorm on strategies to implement smart approaches with the help of…

Out of 860 nominations, Cadila was chosen for two awards at an event organised by Legasis group

The Technology Summit served as a forum for showcasing opportunities for Indo-Dutch collaboration across key areas as well as for…

The findings of the report confirm the downward trend seen over the last few years and show that EU guidance and national…

The company is facing more than 13,000 lawsuits tied to anti-psychotic drug Risperdal as well as a range of lawsuits involving its…

Mylan will be in a position to launch the product in India soon after receiving approvals from DCGI," Mylan's Global President and…